Miller, K <br/><br/>
Erythropoietin, with and without granulocyte-colony stimulating factor (G-CSF), in the treatment of myelodysplastic syndrome (MDS) patients.  [electronic resource] 

 -  Leukemia research  May 1998 
 - S13-6 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Review 
<br/><br/><label>ISSN: </label>0145-2126 
<br/><br/><label>Standard No.: </label>10.1016/s0145-2126(98)00035-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Clinical Trials as Topic<br/>Drug Therapy, Combination<br/>Erythropoietin--therapeutic use<br/>Granulocyte Colony-Stimulating Factor--therapeutic use<br/>Humans<br/>Myelodysplastic Syndromes--drug therapy<br/>Recombinant Proteins<br/>Treatment Outcome